about
Primary systemic amyloidosis initially presenting with digestive symptoms: a case report and review of the literatureRationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosisFluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutionsAmyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy.Cardiac amyloidosis responding to bortezomib: case report and review of literature.Diagnosis and typing of systemic amyloidosis: The role of abdominal fat pad fine needle aspiration biopsyA Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosisClinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myelomaIn vitro aggregation behavior of a non-amyloidogenic λ light chain dimer deriving from U266 multiple myeloma cells.Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation.Systemic AA amyloidosis: epidemiology, diagnosis, and management.Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis.C-src enriched serum microvesicles are generated in malignant plasma cell dyscrasia.Site-directed mutagenesis reveals regions implicated in the stability and fiber formation of human λ3r light chainsEstimation of Daily Proteinuria in Patients with Amyloidosis by Using the Protein-To-Creatinine ratio in Random Urine Samples.High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement.Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience.Detection of high-molecular-weight amyloid serum protein complexes using biological on-line tracer sedimentation.Al amyloidosisIncomplete ileus and hemafecia as the presenting features of multi-organ involved primary systemic AL amyloidosis: a rare case report.Deposition-associated diseases related with a monoclonal compound.Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts.Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis.Protein folding and cutaneous diseases.Treatment of immunoglobulin light chain amyloidosis.Management of hematological malignancies in patients affected by renal failure.Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: a case report and literature review.Cardiac amyloidosis: the heart of the matter.Amyloidotic cardiomyopathy: multidisciplinary approach to diagnosis and treatment.Immunotherapeutic implication of IL-6 blockade.Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.Light chain amyloidosis 2012: a new era.Systemic amyloidoses.Decreasing incidence of AA amyloidosis in Spain.Current treatments for renal failure due to multiple myeloma.Pathophysiology and treatment of systemic amyloidosis.A case of systemic amyloidosis associated with cyclic neutropenia.Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation.Enhanced transthyretin tetramer stability following expression of an amyloid disease transsuppressor variant in mammalian cells.
P2860
Q26782691-0900457A-F9ED-4F3D-B5FD-FEFB8A0DBBEFQ28069975-5F2BBB04-D27A-49C6-8692-2FAC6DF25EB0Q31072074-C831AAC4-4AA1-47B8-ACB1-D368AE8E8B84Q33334024-7A6953B4-39C3-400A-A12F-AE5D09AC2C8DQ33597057-A1CFED6B-2BF4-4C25-A46E-82AFB996CBC0Q33654026-D0C1EA62-B109-4530-8E25-7B3E738D9BD8Q33654101-31BD8A60-D259-49BC-801A-4BF0D22C7FD8Q33718805-3734F54F-6B4F-4D60-9F26-767600D5A1E2Q33744195-21132033-071D-43EB-A8C3-D6EBDC8225DAQ34202885-198AF818-34CD-4D59-B18D-FF4545A121ABQ34216798-8E27FC5C-E980-45E9-AD94-9DBAA3EC7802Q34446219-DDA3ED0B-9989-47D0-A311-2E1A4A025DC3Q34646212-DA979E75-5CFB-4D59-A962-6690EA46B9F9Q34936088-E0D28A79-DDA8-4BF1-B276-6E6BAC8550E1Q35048946-0FDA459D-B00E-4531-A180-E0514255E38AQ35289929-7724327A-DF6C-4B53-B6E7-99B72B926F52Q35750326-C86ED5B1-DD7A-4881-A091-F16BA57F4777Q35834954-22D3A3E6-97B2-4AB3-9961-251A01F97D8DQ35966921-19E6D043-F25E-44FE-BE20-1182C2D1A5C5Q36392233-665555F4-E4D4-4C97-B937-D8C8C326015BQ36393248-F0505087-404E-4EDC-A007-89688D566C80Q37045073-F84440B4-4BCF-48DE-8330-3DA7B000F377Q37076423-0337E70B-F5AF-4E09-AB02-3E7E32B9EA23Q37247207-6B64F7CC-3A00-4126-BB5A-01843AB588A3Q37363331-9C5D56B5-5B99-491E-B056-43314401FE21Q37738576-CD6EB1F3-EF76-4D70-9B6D-030E1E889A1BQ37854710-5A17B0F9-EA67-453D-B2E5-2E3997A50B30Q37866798-864E19BF-7EDE-4B80-82B7-697545E935D4Q37899075-CB52E28F-E005-43CF-8D0C-8A801AF259BDQ37900401-311A4B2A-0164-4429-8C65-3DBAA2C9411EQ37965754-4C7BF48F-34AE-4E26-B159-7C62D0CAC635Q38058508-B8B97AC0-07D2-4D1E-A49B-0CFA1DE8E184Q38072108-067607B5-3FBE-4ECA-9088-E44B4B43B969Q38085664-3728FB1F-D35F-4A0E-8426-FE5E0835DE8CQ38107554-5F6F021B-B19D-4850-8A07-48767431F30DQ38109235-81B4EA6C-FD80-40DA-ADC0-D4500930F696Q38131710-58811227-1CBE-403C-8668-31DD88385C23Q38478889-906697E8-E73B-4877-BD5A-40AE4D72A4D8Q39159810-BCF6CA58-4FF0-496C-BF8B-6D05D7504813Q39907623-774941C5-5AE6-4DBF-85C6-1CC14C80BE69
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Clinical aspects of systemic amyloid diseases.
@ast
Clinical aspects of systemic amyloid diseases.
@en
type
label
Clinical aspects of systemic amyloid diseases.
@ast
Clinical aspects of systemic amyloid diseases.
@en
prefLabel
Clinical aspects of systemic amyloid diseases.
@ast
Clinical aspects of systemic amyloid diseases.
@en
P50
P1476
Clinical aspects of systemic amyloid diseases
@en
P2093
Remigio Moratti
Vittorio Perfetti
P356
10.1016/J.BBAPAP.2005.08.014
P407
P577
2005-09-02T00:00:00Z